Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

431 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Efficacy and tolerability of tropisetron in primary fibromyalgia--a highly selective and competitive 5-HT3 receptor antagonist. German Fibromyalgia Study Group.
Färber L, Stratz T, Brückle W, Späth M, Pongratz D, Lautenschläger J, Kötter I, Zöller B, Peter HH, Neeck G, Alten R, Müller W. Färber L, et al. Among authors: peter hh. Scand J Rheumatol Suppl. 2000;113:49-54. doi: 10.1080/030097400446643. Scand J Rheumatol Suppl. 2000. PMID: 11028832 Clinical Trial.
Short-term treatment of primary fibromyalgia with the 5-HT3-receptor antagonist tropisetron. Results of a randomized, double-blind, placebo-controlled multicenter trial in 418 patients.
Färber L, Stratz TH, Brückle W, Späth M, Pongratz D, Lautenschläger J, Kötter I, Zöller B, Peter HH, Neeck G, Welzel D, Müller W; German Fibromyalgia Study Group. Färber L, et al. Among authors: peter hh. Int J Clin Pharmacol Res. 2001;21(1):1-13. Int J Clin Pharmacol Res. 2001. PMID: 11708570 Clinical Trial.
[Vasculitis update - giant cell arteritis].
Peter HH, Gross WL, Kötter I. Peter HH, et al. Z Rheumatol. 2009 Mar;68(2):99. doi: 10.1007/s00393-008-0373-7. Z Rheumatol. 2009. PMID: 19225788 German. No abstract available.
Autologous haematopoietic stem cell transplants for autoimmune disease--feasibility and transplant-related mortality. Autoimmune Disease and Lymphoma Working Parties of the European Group for Blood and Marrow Transplantation, the European League Against Rheumatism and the International Stem Cell Project for Autoimmune Disease.
Tyndall A, Fassas A, Passweg J, Ruiz de Elvira C, Attal M, Brooks P, Black C, Durez P, Finke J, Forman S, Fouillard L, Furst D, Holmes J, Joske D, Jouet J, Kötter I, Locatelli F, Prentice H, Marmont AM, McSweeney P, Musso M, Peter HH, Snowden JA, Sullivan K, Gratwohl A, et al. Tyndall A, et al. Among authors: peter hh. Bone Marrow Transplant. 1999 Oct;24(7):729-34. doi: 10.1038/sj.bmt.1701987. Bone Marrow Transplant. 1999. PMID: 10516675 Clinical Trial.
Phase I/II trial of autologous stem cell transplantation in systemic sclerosis: procedure related mortality and impact on skin disease.
Binks M, Passweg JR, Furst D, McSweeney P, Sullivan K, Besenthal C, Finke J, Peter HH, van Laar J, Breedveld FC, Fibbe WE, Farge D, Gluckman E, Locatelli F, Martini A, van den Hoogen F, van de Putte L, Schattenberg AV, Arnold R, Bacon PA, Emery P, Espigado I, Hertenstein B, Hiepe F, Kashyap A, Kötter I, Marmont A, Martinez A, Pascual MJ, Gratwohl A, Prentice HG, Black C, Tyndall A. Binks M, et al. Among authors: peter hh. Ann Rheum Dis. 2001 Jun;60(6):577-84. doi: 10.1136/ard.60.6.577. Ann Rheum Dis. 2001. PMID: 11350846 Free PMC article. Clinical Trial.
431 results